Alternatives to warfarin--the next generation of anticoagulants

Cardiovascular Therapeutics
Pamala KanagasabapathyAlex Gatt

Abstract

Anticoagulation therapy plays an important role in the management of cardiovascular disease. Currently, oral anticoagulation therapy is reliant on vitamin K antagonists (VKA). In clinical practice, VKA present several limitations including a narrow therapeutic window and frequent drug and food interactions. Despite the clear clinical need for alternative anticoagulants it is only within the last decade that significant progress has been made. These new anticoagulants target specific factors in the hemostatic network and appear to overcome some of the difficulties seen with VKA. Many have now progressed to phase III clinical trials including patients with cardiovascular disease. This review aims to highlight the exciting progress that has been made in the development of these new anticoagulants. It will focus on the key agents that have demonstrated the most promise in clinical trials to date. This will include data on cardiovascular indications for anticoagulant therapy. Finally, the review aims to analyze the future prospects for these new agents. Several issues remain to be addressed for these agents to finally replace vitamin K antagonists as the mainstay of anticoagulant therapy.

References

Aug 1, 1992·Journal of Internal Medicine·M NordströmT Kjellström
Mar 20, 2002·Circulation·Marc A Brouwer, Freek W A Verheugt
Sep 12, 2003·The New England Journal of Medicine·Elaine M HylekDaniel E Singer
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Gregory W AlbersUNKNOWN SPORTIF Executive Steering Committee for the SPORTIF V Investigators
Jan 13, 2006·European Heart Journal·S E HustedA Kher
Jan 18, 2006·British Journal of Haematology·T P BaglinUNKNOWN British Committee for Standards in Haematology
May 5, 2006·Seminars in Thrombosis and Hemostasis·Harold R RobertsDougald M Monroe
May 13, 2006·Journal of Thrombosis and Haemostasis : JTH·M W LankiewiczP M Blatt
Jun 29, 2006·British Journal of Haematology·Shannon M Bates, Jeffrey I Weitz
Mar 21, 2007·Journal of Thrombosis and Haemostasis : JTH·I A NaessJ Hammerstrøm
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·J Ansell
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·J I Weitz
Sep 15, 2007·The New England Journal of Medicine·UNKNOWN van Gogh InvestigatorsGary E Raskob
Sep 15, 2007·The New England Journal of Medicine·UNKNOWN van Gogh InvestigatorsGary E Raskob
May 21, 2008·Journal of Thrombosis and Haemostasis : JTH·L PollerJ Jespersen
Jun 11, 2008·Journal of Thrombosis and Haemostasis : JTH·UNKNOWN Botticelli Investigators, Writing CommitteA Segers
Jun 27, 2008·The New England Journal of Medicine·Bengt I ErikssonUNKNOWN RECORD1 Study Group
Jun 27, 2008·The New England Journal of Medicine·Michael R LassenUNKNOWN RECORD3 Investigators
Jul 17, 2008·Journal of Thrombosis and Haemostasis : JTH·S M ThackerB F Gage
Jul 24, 2008·Journal of Thrombosis and Haemostasis : JTH·P SaviJ M Herbert
Aug 7, 2009·The New England Journal of Medicine·Michael Rud LassenRonald J Portman
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Dec 8, 2009·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-COVER Study Group
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski

❮ Previous
Next ❯

Citations

Jun 10, 2014·American Journal of Human Biology : the Official Journal of the Human Biology Council·Y ZhongC M Schooling
Jun 12, 2013·Thrombosis Research·Guillaume CaylaJean-François Schved
Mar 13, 2014·Drug Discovery Today·Erasmia BroussalisMonika Killer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.